Slate Stone Wealth, LLC Dexcom Inc Transaction History
Slate Stone Wealth, LLC
- $923 Million
- Q2 2024
A detailed history of Slate Stone Wealth, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 2,294 shares of DXCM stock, worth $165,718. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,294
Previous 1,773
29.39%
Holding current value
$165,718
Previous $246,000
5.69%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,075Shares Held
362MCall Options Held
4.1MPut Options Held
3.61M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.36 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.49 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.18 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.11 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$863 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...